CODON-OPTIMISED SEQUENCES AND PHARMACEUTICAL COMPOSITION FOR RECOVERY OF BLOOD VESSELS Russian patent published in 2015 - IPC C12N15/00 

Abstract RU 2557385 C1

FIELD: biotechnology.

SUBSTANCE: codon-optimised cDNA are declared, encoding the stromal cell factor 1 alpha and the vascular endothelial growth factor of isoform 165, and also a recombinant plasmid containing them. The recombinant plasmid can be used as part of a pharmaceutical composition for the recovery of blood vessels and improvement of blood supply in the damaged tissues or organs.

EFFECT: invention enables to increase the efficiency of use of gene products.

4 cl, 5 dwg

Similar patents RU2557385C1

Title Year Author Number
COMPOSITIONS AND METHODS FOR EXPRESSING SEVERAL BIOLOGICALLY ACTIVE POLYPEPTIDES FROM ONE VECTOR FOR THE TREATMENT OF HEART DISEASES AND OTHER PATHOLOGIES 2016
  • Patel Dimki S.
  • Patel Amit N.
RU2758489C2
METHOD FOR STIMULATING RECOVERED PERIPHERAL TISSUE INNERVATION 2011
  • Parfenova Elena Viktorovna
  • Tkachuk Vsevolod Arsen'Evich
  • Rubina Ksenija Andreevna
  • Kalinina Natal'Ja Igorevna
  • Karagjaur Maksim Nikolaevich
  • Stambol'Skij Dmitrij Viktorovich
  • Semina Ekaterina Vladimirovna
  • Lopatina Tat'Jana Vladimirovna
  • Sysoeva Veronika Jur'Evna
RU2486918C1
VEGFopt GENE OF HUMAN VASCULAR ENDOTHELIAL GROWTH FACTOR 2008
  • Vlasik Tat'Jana Nikolaevna
  • Shevelev Aleksandr Jasenovich
  • Parfenova Elena Viktorovna
  • Tkachuk Vsevolod Arsen'Evich
  • Rubina Ksenija Andreevna
  • Kalinina Natal'Ja Igorevna
  • Kashirina Natal'Ja Mikhajlovna
RU2385937C1
CODON-OPTIMISED RECOMBINANT PLASMID, STIMULATION TECHNIQUE FOR PERIPHERAL NERVE REGENERATION, TREATMENT MODALITY FOR DAMAGED HUMAN NERVE 2014
  • Rizvanov Al'Bert Anatol'Evich
  • Bogov Andrej Alekseevich
  • Masgutov Ruslan Faridovich
  • Bogov Aleksej Andreevich
  • Salafutdinov Il'Nur Il'Dusovich
  • Isaev Artur Aleksandrovich
  • Deev Roman Vadimovich
  • Bozo Il'Ja Jadigerovich
  • Plaksa Igor' Leonidovich
RU2558294C1
METHOD FOR REPARATIVE ANGIOGENESIS STIMULATION AND CONNECTIVE TISSUE REGENERATION IN CASE OF ITS DAMAGE, BY THE GENETIC THERAPY METHOD USING SPECIES-SPECIFIC VEGF AND FGF2 PROTEIN FACTORS GENES IN VETERINARY MEDICINE, AND GENETIC STRUCTURE FOR IMPLEMENTATION OF METHOD 2015
  • Kovac Milomir
  • Litvin Yaroslav Aleksandrovich
  • Kovach Milomir
  • Zhuravleva Margarita Nikolaevna
  • Zakirova Elena Yurevna
RU2614665C1
METHOD FOR PRODUCING PREPARATION OF GENETICALLY MODIFIED CELLS 2009
  • Islamov Rustem Robertovich
  • Rizvanov Al'Bert Anatol'Evich
  • Blatt Natal'Ja L'Vovna
  • Gazizov Il'Naz Marselevich
  • Jylmaz Tat'Jana Sergeevna
  • Kaligin Maksim Sergeevich
  • Kiselev Sergej L'Vovich
  • Kudrjashova Nezhdana Vladimirovna
  • Lannik Natal'Ja Ivanovna
  • Salafutdinov Il'Nur Il'Dusovich
  • Shafigullina Ajgul' Kasyjmovna
  • Shakhin Fikrettin
  • Junusov Dinar Shamilevich
  • Jalvach Mekhmet Ehmir
  • Kijasov Andrej Pavlovich
RU2431669C2
METHOD OF STIMULATING REPARATIVE ANGIOGENESIS AND REGENERATION OF SKIN OF DOGS WITH DAMAGE THEREOF BY GENE THERAPY USING SPECIES-SPECIFIC GENES OF PROTEIN FACTORS VEGF AND FGF2 IN VETERINARY SCIENCE AND GENETIC CONSTRUCT FOR REALIZING DECLARED METHOD 2019
  • Rizvanov Albert Anatolevich
  • Zakirova Elena Yurevna
  • Ajmaletdinov Aleksandr Maazovich
  • Aleksandrova Natalya Mikhajlovna
  • Sofronova Svetlana Anatolevna
  • Zhuravleva Margarita Nikolaevna
  • Valeeva Anastasiya Nikolaevna
RU2719513C1
GENE-THERAPEUTIC DNA-VECTOR BASED ON GENE-THERAPEUTIC DNA-VECTOR VTVAF17, CARRYING TARGET GENE SELECTED FROM GROUP OF GENES ANG, ANGPT1, VEGFA, FGF1, HIF1Α, HGF, SDF1, KLK4, PDGFC, PROK1, PROK2 TO INCREASE EXPRESSION LEVEL OF SAID TARGET GENES, METHOD FOR PRODUCTION AND USE THEREOF, STRAIN ESCHERICHIA COLI SCS110-AF/VTVAF17-ANG, OR ESCHERICHIA COLI SCS110-AF/VTVAF17-ANGPT1, OR ESCHERICHIA COLI SCS110-AF/VTVAF17-VEGFA, OR ESCHERICHIA COLI SCS110-AF/VTVAF17-FGF1, OR ESCHERICHIA COLI SCS110-AF/VTVAF17-HIF1Α, OR ESCHERICHIA COLI SCS110-AF/VTVAF17-HGF, OR ESCHERICHIA COLI SCS110-AF/VTVAF17-SDF1, OR ESCHERICHIA COLI SCS110-AF/VTVAF17-KLK4, OR ESCHERICHIA COLI SCS110-AF/VTVAF17-PDGFC, OR ESCHERICHIA COLI SCS110-AF/VTVAF17-PROK1, OR ESCHERICHIA COLI SCS110-AF/VTVAF17-PROK2, CARRYING GENE-THERAPEUTIC DNA VECTOR, METHOD FOR PRODUCTION THEREOF, METHOD FOR INDUSTRIAL PRODUCTION OF GENE-THERAPEUTIC DNA VECTOR 2018
  • Savelieva Natalia
RU2730664C2
GENE PDGF-Bopt PLATELET GROWTH FACTOR 2014
  • Parfenova Elena Viktorovna
  • Shevchenko Evgenij Konstantinovich
  • Makarevich Pavel Igorevich
  • Tsokolaeva Zoya Ivanovna
  • Boldyreva Mariya Aleksandrovna
  • Tkachuk Vsevolod Arsenevich
RU2590704C2
GENE ENGINEERED VEGF-IBMED CONSTRUCT 2005
  • Itkes Aleksandr Ven'Jaminovich
  • Kiselev Sergej L'Vovich
RU2297848C2

RU 2 557 385 C1

Authors

Rizvanov Al'Bert Anatol'Evich

Solov'Eva Valerija Vladimirovna

Salafutdinov Il'Nur Il'Dusovich

Isaev Artur Aleksandrovich

Deev Roman Vadimovich

Bozo Il'Ja Jadigerovich

Dates

2015-07-20Published

2014-06-18Filed